market access strategy

7.23.2014 Marketing

Possibilities Abound for Big Data in Pharma

By Ryan McGuire, Head of Research The uses for Big Data in pharma are limitless.  Commercial, clinical and market access teams can all benefit from Big Data insights.  With so many options, it’s no wonder some companies get decision paralysis...
 

7.15.2014 Account Strategy for Payer Organizations

Delivering a Payer Value Proposition in Managed Markets: The Role of MSLs, MCLs and HOLs

By Natalie DeMasi, Research Analyst In this era of increasing healthcare spending scrutiny, the onus is on managed markets account managers to deliver a persuasive payer value proposition.  In meetings about formularies, payers will want to see...
 

7.9.2014 Health Economics and Outcomes Research (HEOR)

Protecting Profitability: Translating Strong Health Economics and Outcomes Research to Drive Interactions with Medical Device Payers and More

By Victoria Cavicchi, Research Analyst Health economics and outcomes research (HEOR) groups have carved out their place in life sciences organizations throughout the industry. Though pharmaceutical and biotech companies have long-since accepted...
 

6.10.2014 Account Strategy for Payer Organizations

Pharmaceutical Reimbursement Strategy: What We Can All Learn From Winnie the Pooh

By Jacob Presson, Senior Research Analyst Working with payers and hospitals in order to maintain profitability is a key role for managed markets groups and the account managers responsible for these contacts. Payers are becoming increasingly interested...
 

3.24.2014 Market Access

Patient-Reported Outcomes Spurred by Big Data in Pharma

By Nicole May, Research Analyst The opportunities are countless for Big Data in pharma, particularly within the clinical trial space.  Harnessing the data generated during clinical trials could help shorten trial timelines and lead to less expensive...
 

2.26.2014 Account Strategy for Payer Organizations

Provide a Framework for New Product Planning Groups to Influence Clinical Trials

By Jacob Presson, Research Analyst A common theme running through a lot of what we at Cutting Edge Information learn while conducting research on the pharmaceutical industry is the need for more consistent and productive communication between internal...
 

11.7.2013 Health Economics and Outcomes Research (HEOR)

HEORs and Tails: Why Is Staffing Market Access Teams So Difficult?

By Christie Shilling, Research Analyst Pharmaceutical market access teams hold a wide range of responsibilities and, as such, require employees with a variety of knowledge and skills.  Organizations that create a well-rounded market access team...
 

9.10.2013 Market Access

Product Pricing in Emerging Markets

By Yanis Saradjian, Director of Consulting In today’s global market, life science companies worldwide face challenges such as increased austerity measures, unfamiliar emerging markets payers and governments, greater emphasis on health economics...
 

8.6.2013 Account Strategy for Government

Government Affairs Teams: Promoting Patient Education and Access

By Sarah Ray, Research Analyst When it comes to healthcare in the US, the 10th annual National Healthcare Disparities Report — released earlier this year — shows that the quality of patient care is improving.  Yet when it comes to patient access,...
 

8.1.2013 Health Economics and Outcomes Research (HEOR)

Market Access Success: It’s All About Timing

By Natalie DeMasi, Research Analyst A good cook doesn’t just throw together all of the ingredients and hope everything turns out okay. Take a grilled cheese sandwich, for example. You melt butter before putting bread in a skillet, and you don’t...